The research, funded by the British Heart Foundation and published in the journal Circulation, opens the prospect of treating the condition at the earliest stages.
Helsinn and Angelini Pharma renew distribution deal
The medicines are indicated for usage as a second line treatment option for acute pain and primary dysmenorrhea. Credit: Kmpzzz / Shutterstock.com. Helsinn Group has